Clinical Trial Update: A Study to Determine Safety, Feasibility and Efficacy of JCAR015 in Adult Subjects With B-Cell Acute Lymphoblastic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating JCAR015 in adults with B-cell acute lymphoblastic leukemia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia
• Precursor B-cell Lymphoblastic Leukemia Lymphoma

Drugs mentioned

• JCAR015

Snippet

Sponsor: Celgene | Conditions: Precursor Cell Lymphoblastic Leukemia-Lymphoma | Phase 1, Phase 2 | Status: WITHDRAWN